{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:22:17Z","timestamp":1790875337106,"version":"4.1.0"},"reference-count":20,"publisher":"Becaris Publishing Limited","issue":"3","funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>\n            <jats:bold>Aim:<\/jats:bold>\n            Durability of aortic valve replacement is becoming increasingly important. Aortic bioprostheses with RESILIA tissue have demonstrated outstanding outcomes thus far, but only in single-arm studies.\n            <jats:bold>Methods:<\/jats:bold>\n            We compared structural valve deterioration (SVD)-related hemodynamic valve deterioration (HVD) of grade \u22652 of RESILIA tissue valves from the COMMENCE trial (n\u00a0=\u00a0689) to those from the PARTNER 2A contemporary AVR arm (n\u00a0=\u00a0936) based upon annual core laboratory echocardiograms through 5\u00a0years of follow-up.\n            <jats:bold>Results:<\/jats:bold>\n            SVD-related HVD in the COMMENCE and PARTNER 2A cohorts were 1.8\u00a0versus 3.5%, respectively (one-sided 95% lower-bound hazard ratio of\u00a00.92;\u00a0p\u00a0=\u00a00.07). In propensity-matched cohorts (n\u00a0=\u00a0239), these outcomes were 1.0\u00a0versus 4.8%, respectively (one-sided 95% lower-bound hazard ratio of 1.15;\u00a0p\u00a0=\u00a00.03).\n            <jats:bold>Conclusion:<\/jats:bold>\n            RESILIA tissue-based AVR exhibited reduced SVD-related HVD compared with a contemporary AVR cohort devoid of RESILIA tissue.\n          <\/jats:p>","DOI":"10.2217\/cer-2022-0180","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T07:35:21Z","timestamp":1674545721000},"source":"Crossref","is-referenced-by-count":24,"title":["Structural hemodynamic valve deterioration durability of RESILIA-tissue versus contemporary aortic bioprostheses"],"prefix":"10.57264","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3457-6978","authenticated-orcid":false,"given":"Krzysztof","family":"Bartus","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery &amp; Transplantology, Jagiellonian University Medical College, Institute of Cardiology, John Paul II Hospital, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E","family":"Bavaria","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod H","family":"Thourani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[{"name":"Edwards Lifesciences, Irvine, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L","family":"Keuffel","sequence":"additional","affiliation":[{"name":"Health Finance &amp; Access Initiative, Ardmore, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"36897","reference":[{"issue":"4","key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 77(4), e25\u2013e197 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"e_1_3_5_4_2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.athoracsur.2014.09.030","article-title":"Very long-term outcomes of the Carpentier\u2013Edwards PERIMOUNT valve in aortic position","volume":"99","author":"Bourguignon T","year":"2015","unstructured":"Bourguignon T, Bouquiaux-Stablo AL, Candolfi P Very long-term outcomes of the Carpentier\u2013Edwards PERIMOUNT valve in aortic position. Ann. Thorac. Surg. 99(3), 831\u2013837 (2015).","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"e_1_3_5_5_2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.athoracsur.2014.10.070","article-title":"Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants","volume":"99","author":"Johnston DR","year":"2015","unstructured":"Johnston DR, Soltesz EG, Vakil N Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann. Thorac. Surg. 99(4), 1239\u20131247 (2015).","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jtcvs.2019.05.081","article-title":"Surgical valve selection in the era of transcatheter aortic valve replacement in the Society of Thoracic Surgeons Database","volume":"159","author":"Tam DY","year":"2020","unstructured":"Tam DY, Rocha RV, Wijeysundera HC, Austin PC, Dvir D, Fremes SE. Surgical valve selection in the era of transcatheter aortic valve replacement in the Society of Thoracic Surgeons Database. J. Thorac. Cardiovasc. Surg. 159(2), 416\u2013427.e418 (2020).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"e_1_3_5_7_2","first-page":"101","article-title":"Advanced integrity preservation technology reduces bioprosthesis calcification while preserving performance and Safety","volume":"24","author":"De La Fuente AB","year":"2015","unstructured":"De La Fuente AB, Wright GA, Olin JM Advanced integrity preservation technology reduces bioprosthesis calcification while preserving performance and Safety. J. Heart Valve Dis. 24(1), 101\u2013109 (2015).","journal-title":"J. Heart Valve Dis."},{"issue":"1","key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10856-016-5829-8","article-title":"Aldehyde reduction in a novel pericardial tissue reduces calcification using rabbit intramuscular model","volume":"28","author":"Shang H","year":"2017","unstructured":"Shang H, Claessens SM, Tian B, Wright GA. Aldehyde reduction in a novel pericardial tissue reduces calcification using rabbit intramuscular model. J. Mater. Sci Mater. Med. 28(1), 16 (2017).","journal-title":"J. Mater. Sci Mater. Med."},{"issue":"1","key":"e_1_3_5_9_2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jtcvs.2014.09.062","article-title":"A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model","volume":"149","author":"Flameng W","year":"2015","unstructured":"Flameng W, Hermans H, Verbeken E, Meuris B. A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model. J. Thorac. Cardiovasc. Surg. 149(1), 340\u2013345 (2015).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jtcvs.2007.12.002","article-title":"Guidelines for reporting mortality and morbidity after cardiac valve interventions","volume":"135","author":"Akins CW","year":"2008","unstructured":"Akins CW, Miller DC, Turina MI Guidelines for reporting mortality and morbidity after cardiac valve interventions. J. Thorac. Cardiovasc. Surg. 135(4), 732\u2013738 (2008).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"e_1_3_5_11_2","article-title":"Five-year outcomes of the COMMENCE trial investigating aortic valve replacement with RESILIA tissue","author":"Bavaria JE","year":"2022","unstructured":"Bavaria JE, Griffith B, Heimansohn DA Five-year outcomes of the COMMENCE trial investigating aortic valve replacement with RESILIA tissue. Ann. Thorac. Surg. doi:10.1016\/j.athoracsur.2021.12.058 (2022).","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"e_1_3_5_12_2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/ejcts\/ezx158","article-title":"The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue","volume":"52","author":"Puskas JD","year":"2017","unstructured":"Puskas JD, Bavaria JE, Svensson LG The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue. Eur. J. Cardiothorac. Surg. 52(3), 432\u2013439 (2017).","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"9","key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-year outcomes of transcatheter or surgical aortic-valve replacement","volume":"382","author":"Makkar RR","year":"2020","unstructured":"Makkar RR, Thourani VH, Mack MJ Five-year outcomes of transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 382(9), 799\u2013809 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"e_1_3_5_14_2","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jacc.2020.08.049","article-title":"Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial","volume":"76","author":"Pibarot P","year":"2020","unstructured":"Pibarot P, Ternacle J, Jaber WA Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial. J. Am. Coll. Cardiol. 76(16), 1830\u20131843 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux P","year":"2021","unstructured":"G\u00e9n\u00e9reux P, Piazza N, Alu MC Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. J. Am. Coll. Cardiol. 77(21), 2717\u20132746 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"e_1_3_5_16_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/HCO.0000000000000372","article-title":"Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration","volume":"32","author":"Cote N","year":"2017","unstructured":"Cote N, Pibarot P, Clavel MA. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration. Curr. Opin. Cardiol. 32(2), 123\u2013129 (2017).","journal-title":"Curr. Opin. Cardiol."},{"issue":"17","key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon MB","year":"2016","unstructured":"Leon MB, Smith CR, Mack MJ Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med. 374(17), 1609\u20131620 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"e_1_3_5_18_2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/icvts\/ivab016","article-title":"Magna Ease bioprosthetic aortic valve: mid-term haemodynamic outcomes in 1126 patients","volume":"32","author":"Thorp SD","year":"2021","unstructured":"Thorp SD, Khazaal J, Yu G, Parker JL, Timek TA. Magna Ease bioprosthetic aortic valve: mid-term haemodynamic outcomes in 1126 patients. Interact. Cardiovasc. Thorac. Surg. 32(6), 839\u2013845 (2021).","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"4","key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/ejcts\/ezab552","article-title":"Carpentier\u2013Edwards Magna Ease bioprosthesis: a multicentre clinical experience and 12-year durability","volume":"61","author":"Piperata A","year":"2022","unstructured":"Piperata A, Fiocco A, Cavicchiolo A Carpentier\u2013Edwards Magna Ease bioprosthesis: a multicentre clinical experience and 12-year durability. Eur. J. Cardiothorac. Surg. 61(4), 888\u2013896 (2022).","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"2","key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ejcts\/ezaa311","article-title":"Final 5-year outcomes following aortic valve replacement with a RESILIA\u2122 tissue bioprosthesis","volume":"59","author":"Bartus K","year":"2021","unstructured":"Bartus K, Litwinowicz R, Bilewska A Final 5-year outcomes following aortic valve replacement with a RESILIA\u2122 tissue bioprosthesis. Eur. J. Cardiothorac. Surg. 59(2), 434\u2013441 (2021).","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"5","key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5603\/KP.a2014.0214","article-title":"Aortic valve replacement with a novel anti-calcification technology platform","volume":"73","author":"Sadowski J","year":"2015","unstructured":"Sadowski J, Bartu\u015b K, Kapelak B, Chung A, St\u0105por M, Bochenek M. Aortic valve replacement with a novel anti-calcification technology platform. Kardiol. Pol. 73(5), 317\u2013322 (2015).","journal-title":"Kardiol. Pol."},{"issue":"3","key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.5603\/KP.a2017.0262","article-title":"Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes","volume":"76","author":"Bartu\u015b K","year":"2018","unstructured":"Bartu\u015b K, Litwinowicz R, Ku\u015bmierczyk M Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes. Kardiol. Pol. 76(3), 618\u2013624 (2018).","journal-title":"Kardiol. Pol."}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.2217\/cer-2022-0180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T13:15:59Z","timestamp":1679231759000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.2217\/cer-2022-0180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.2217\/cer-2022-0180"],"URL":"https:\/\/doi.org\/10.2217\/cer-2022-0180","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]},"article-number":"e220180"}}